Noble Capital Markets Investments

Noble Capital Markets has invested in 2 companies and its latest investment was Onconova Therapeutics on Sep 27, 2021

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Onconova is a Pennsylvania-based biopharmaceutical company that develops and commercializes novel products for the treatment of cancer.
$21M
Sep 27, 2021
-
OST is an-England based clinical stage biopharmaceutical company that research and develops products for the treatment of osteosarcoma and other solid tumors.
$6M
Apr 19, 2021
-

Frequently Asked Questions about Noble Capital Markets

  1. What is Noble Capital Markets investing in?

    Noble Capital Markets has invested in 2 companies including Onconova Therapeutics and OS Therapies
  2. What company did Noble Capital Markets invest in?

    Noble Capital Markets invested in a total 2 companies including Onconova Therapeutics and OS Therapies
  1. What are the top 2 investments by Noble Capital Markets?

    The top companies in which Noble Capital Markets invested are Onconova Therapeutics and OS Therapies